Join
Live feed
·
INSIDERFilingvia Quantisnow
Agios Pharmaceuticals Inc. logo

Chief Medical Officer Gheuens Sarah converted options into 13,500 shares and sold $142,338 worth of shares (4,005 units at $35.54), increasing direct ownership by 21% to 53,897 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGIO (Agios Pharmaceuticals Inc.) and more on Quantisnow.